Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
16.06
-0.38 (-2.31%)
Sep 16, 2026, 3:18 PM EDT - Market open
Janux Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 24 | 13.73 | 10 | 10 | 0.44 | 9.34 | 10.59 | 13.05 | 15.13 | 7.29 | 8.08 | 8.47 | 7.76 | 9.07 | 8.61 | 7.38 | 6.73 | 4.85 | 3.64 | 2.02 | |
Revenue Growth (YoY) | 5366.97% | 47.10% | -5.55% | -23.37% | -97.10% | 28.12% | 30.99% | 54.12% | 94.86% | -19.67% | -6.14% | 14.68% | 15.37% | 87.19% | 136.79% | 265.31% | 680.63% | 1175.26% | - | - |
Cost of Revenue | 123.98 | 127.65 | 125.9 | 115.15 | 99.14 | 79.37 | 68.39 | 59.82 | 53.1 | 53.13 | 54.92 | 58.12 | 59.96 | 59.12 | 53.44 | 49.18 | 43.85 | 34.5 | 26.24 | 16.05 |
Gross Profit | -99.98 | -113.92 | -115.9 | -105.15 | -98.7 | -70.04 | -57.8 | -46.77 | -37.97 | -45.84 | -46.84 | -49.65 | -52.2 | -50.05 | -44.83 | -41.79 | -37.12 | -29.65 | -22.6 | -14.03 |
Selling, General & Admin | 43.57 | 43.06 | 41.77 | 39.13 | 46.18 | 43.55 | 41.05 | 39.19 | 27.96 | 27.02 | 26.14 | 25.46 | 25.12 | 23.78 | 22.26 | 20.52 | 18.08 | 14.54 | 10.33 | 7.06 |
Operating Expenses | 43.57 | 43.06 | 41.77 | 39.13 | 46.18 | 43.55 | 41.05 | 39.19 | 27.96 | 27.02 | 26.14 | 25.46 | 25.12 | 23.78 | 22.26 | 20.52 | 18.08 | 14.54 | 10.33 | 7.06 |
Operating Income | -143.56 | -156.98 | -157.67 | -144.29 | -144.88 | -113.58 | -98.85 | -85.96 | -65.93 | -72.86 | -72.98 | -75.11 | -77.32 | -73.83 | -67.09 | -62.32 | -55.2 | -44.19 | -32.93 | -21.09 |
Interest & Investment Income | 40.96 | 42.51 | 44.04 | 42.39 | 39.24 | 35.84 | 29.85 | 25.43 | 21.89 | 17.27 | 14.69 | 12.51 | 9.59 | 6.72 | 4.03 | 1.91 | 0.72 | 0.39 | 0.26 | 0.18 |
EBT Excluding Unusual Items | -102.59 | -114.48 | -113.63 | -101.9 | -105.64 | -77.74 | -68.99 | -60.54 | -44.05 | -55.59 | -58.29 | -62.6 | -67.73 | -67.11 | -63.06 | -60.41 | -54.48 | -43.8 | -32.67 | -20.91 |
Pretax Income | -102.59 | -114.48 | -113.63 | -101.9 | -105.64 | -77.74 | -68.99 | -60.54 | -44.05 | -55.59 | -58.29 | -62.6 | -67.73 | -67.11 | -63.06 | -60.41 | -54.48 | -43.8 | -32.67 | -20.91 |
Net Income | -102.59 | -114.48 | -113.63 | -101.9 | -105.64 | -77.74 | -68.99 | -60.54 | -44.05 | -55.59 | -58.29 | -62.6 | -67.73 | -67.11 | -63.06 | -60.41 | -54.48 | -43.8 | -32.67 | -20.91 |
Net Income to Common | -102.59 | -114.48 | -113.63 | -101.9 | -105.64 | -77.74 | -68.99 | -60.54 | -44.05 | -55.59 | -58.29 | -62.6 | -67.73 | -67.11 | -63.06 | -60.41 | -54.48 | -43.8 | -32.67 | -20.91 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 62 | 62 | 62 | 61 | 59 | 57 | 54 | 51 | 49 | 46 | 44 | 43 | 42 | 42 | 41 | 41 | 41 | 34 | 24 | 13 |
Shares Outstanding (Diluted) | 62 | 62 | 62 | 61 | 59 | 57 | 54 | 51 | 49 | 46 | 44 | 43 | 42 | 42 | 41 | 41 | 41 | 34 | 24 | 13 |
Shares Change (YoY) | 6.20% | 9.22% | 15.28% | 18.41% | 20.02% | 24.21% | 22.12% | 19.85% | 17.55% | 10.23% | 6.14% | 3.16% | 0.62% | 23.82% | 76.24% | 208.43% | 1160.76% | 3300.22% | 2471.20% | - |
EPS (Basic) | -1.64 | -1.84 | -1.83 | -1.68 | -1.80 | -1.37 | -1.28 | -1.18 | -0.90 | -1.21 | -1.32 | -1.46 | -1.63 | -1.61 | -1.52 | -1.46 | -1.32 | -1.30 | -1.39 | -1.56 |
EPS (Diluted) | -1.64 | -1.84 | -1.83 | -1.68 | -1.80 | -1.37 | -1.28 | -1.18 | -0.90 | -1.21 | -1.32 | -1.46 | -1.63 | -1.61 | -1.52 | -1.46 | -1.32 | -1.30 | -1.39 | -1.56 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -41.93 | -78.49 | -83.28 | -71.4 | -60.7 | -46.53 | -44.17 | -37.82 | -47.75 | -53.26 | -52.43 | -55.98 | -59.73 | -51.07 | -49.37 | -47.05 | -37.05 | -36.36 | -18.46 | -8.43 |
Free Cash Flow Per Share | -0.67 | -1.26 | -1.34 | -1.18 | -1.03 | -0.82 | -0.82 | -0.74 | -0.97 | -1.16 | -1.19 | -1.31 | -1.43 | -1.23 | -1.19 | -1.14 | -0.89 | -1.08 | -0.78 | -0.63 |
Gross Margin | - | - | - | - | - | - | - | - | -251.03% | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | -598.15% | -1143.11% | -1576.67% | -1442.88% | -33002.05% | -1216.61% | -933.58% | -658.76% | -435.86% | -999.85% | -902.87% | -887.07% | -995.97% | -813.91% | -779.04% | -844.03% | -820.27% | -911.82% | -905.39% | -1043.74% |
Profit Margin | -427.47% | -833.60% | -1136.25% | -1018.95% | -24064.01% | -832.71% | -651.62% | -463.91% | -291.17% | -762.92% | -721.18% | -739.34% | -872.45% | -739.81% | -732.22% | -818.23% | -809.63% | -903.80% | -898.32% | -1034.69% |
Free Cash Flow Margin | -174.69% | -571.57% | -832.78% | -713.97% | -13827.79% | -498.44% | -417.20% | -289.85% | -315.63% | -730.93% | -648.58% | -661.13% | -769.46% | -563.00% | -573.24% | -637.30% | -550.59% | -750.33% | -507.51% | -417.27% |
EBITDA | -141.65 | -155 | -155.64 | -142.22 | -142.8 | -111.54 | -96.79 | -83.88 | -63.86 | -70.83 | -71.02 | -73.28 | -75.74 | -72.62 | -66.25 | -61.81 | -54.92 | -44 | -32.82 | -21.04 |
D&A For EBITDA | 1.9 | 1.98 | 2.03 | 2.07 | 2.08 | 2.05 | 2.06 | 2.08 | 2.07 | 2.03 | 1.96 | 1.83 | 1.58 | 1.21 | 0.84 | 0.5 | 0.28 | 0.19 | 0.11 | 0.06 |
EBIT | -143.56 | -156.98 | -157.67 | -144.29 | -144.88 | -113.58 | -98.85 | -85.96 | -65.93 | -72.86 | -72.98 | -75.11 | -77.32 | -73.83 | -67.09 | -62.32 | -55.2 | -44.19 | -32.93 | -21.09 |